FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30880011000001107: Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Nov 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95491301000001113 Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
95491401000001117 Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Is a Risperidone 500microgram orodispersible tablets sugar free true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Has active ingredient Risperidone true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Risperidone true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP True Risperidone 500microgram orodispersible tablets sugar free (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start